Aardvark Therapeutics Ownership | Who Owns Aardvark Therapeutics?

Aardvark Therapeutics Ownership Summary

Aardvark Therapeutics is owned by 41.11% institutional investors, 24.03% insiders, and 34.87% retail investors. Decheng capital is the largest institutional shareholder, holding 18.06% of AARD shares.

AARD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Aardvark Therapeutics	41.11%	24.03%	34.87%
Sector	Healthcare Stocks	486.50%	11.08%	-397.59%
Industry	Biotech Stocks	304.14%	11.08%	-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Decheng capital	3.92M	18.06%	$52.96M
Laurion capital management lp	989.07K	4.56%	$13.37M
Cormorant asset management, lp	800.19K	3.69%	$10.82M
Silverarc capital management	286.81K	1.32%	$3.88M
Blackrock funding, inc. /de	205.79K	0.95%	$2.78M
Adage capital partners gp	175.00K	0.81%	$2.37M
Cantor fitzgerald, l. p.	76.68K	0.35%	$1.04M
Sterling capital management	75.00	0.00%	$1.01K
Balyasny asset management	-	-	-
Two sigma investments, lp	-	-	-

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Decheng capital	3.92M	13.38%	$52.96M
Cormorant asset management, lp	800.19K	0.81%	$10.82M
Silverarc capital management	286.81K	0.71%	$3.88M
Laurion capital management lp	989.07K	0.24%	$13.37M
Cantor fitzgerald, l. p.	76.68K	0.02%	$1.04M
Adage capital partners gp	175.00K	0.00%	$2.37M
Blackrock funding, inc. /de	205.79K	0.00%	$2.78M
Squarepoint ops	-	-	-
Balyasny asset management	-	-	-
Walleye capital	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	205.79K	0.00%	187.02K
Laurion capital management lp	989.07K	0.24%	180.82K
Silverarc capital management	286.81K	0.71%	167.31K
Cantor fitzgerald, l. p.	76.68K	0.02%	10.00K
Sterling capital management	75.00	-	75.00

Top Sellers

Holder	Shares	% Assets	Change
Braidwell lp	-	-	-500.00K
Suvretta capital management	-	-	-312.50K
Adage capital partners gp	175.00K	0.00%	-75.00K
Balyasny asset management	-	-	-35.44K
Two sigma investments, lp	-	-	-15.42K

New Positions

Holder	Shares	% Assets	Change	Value
Sterling capital management	75.00	-	75.00	$1.01K

Sold Out

Holder	Change
Point72 asia (singapore) pte.	-1.28K
Walleye capital	-11.73K
Point72 (difc)	-12.80K
Squarepoint ops	-14.19K
Two sigma investments, lp	-15.42K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	35	29.63%	8,915,797	2.64%	41	0.95%	30	11.11%	3	-
Mar 31, 2025	27	-	8,686,452	-	65	-	27	-	-	-
Jun 30, 2015	1	-	1	-	-	-	1	-	-	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 17, 2007	Creamer James W III	CFO & Treasurer	Buy	$950.00
Nov 08, 2006	Creamer James W III	CFO & Treasurer	Buy	$165.00K
Oct 26, 2006	Zimlich Joseph C	-	Buy	$51.00K
Dec 06, 2006	Zimlich Joseph C	-	Buy	$73.52K
May 12, 2006	Creamer James W III	Chief Financial Officer	Buy	$915.00

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2007 Q3	1	-
2007 Q1	-	-
2006 Q4	3	-
2006 Q2	1	-

AARD Ownership FAQ

Who Owns Aardvark Therapeutics?

Aardvark Therapeutics shareholders are primarily institutional investors at 41.10%, followed by 24.03% insiders and 34.87% retail investors. The average institutional ownership in Aardvark Therapeutics's industry, Biotech Stocks , is 304.14%, which Aardvark Therapeutics falls below.

Who owns the most shares of Aardvark Therapeutics?

Aardvark Therapeutics’s largest shareholders are Decheng capital (3.92M shares, 18.06%), Laurion capital management lp (989.07K shares, 4.56%), and Cormorant asset management, lp (800.19K shares, 3.69%). Together, they hold 26.31% of Aardvark Therapeutics’s total shares outstanding.

Does Blackrock own Aardvark Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Aardvark Therapeutics.

Who is Aardvark Therapeutics’s biggest shareholder by percentage of total assets invested?

Decheng capital is Aardvark Therapeutics’s biggest shareholder by percentage of total assets invested, with 13.38% of its assets in 3.92M Aardvark Therapeutics shares, valued at 52.96M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools